In this RAND Remote presentation, Beau Kilmer discusses how RAND is identifying and evaluating innovative approaches to tackle some of America's most pressing drug problems and help strengthen and safeguard communities.
These videos provide an overview of key methodological challenges faced when evaluating the effectiveness of state-level opioid policies using annual state-level data, as well as potential solutions and practice guidelines.
Treatment for opioid addiction and other substance use disorders often exists apart from primary care. It's also difficult to access and under-resourced. In response to these challenges, RAND's Katherine Watkins developed an innovative approach to addiction treatment through primary care settings.
RAND adjunct physician policy researcher Stephen W. Patrick gives testimony at a Senate Health, Education, Labor and Pensions Committee hearing on the impact of the opioid epidemic on children and families.
In this PBS News Hour segment, RAND Behavioral scientist Elizabeth D’Amico, who has researched drug and alcohol use among teens for more than 20 years, discusses what kids need to know about the use of legal marijuana.
In this Call with the Experts, Beau Kilmer, codirector of the RAND Drug Policy Research Center, discusses the controversy surrounding marijuana policy and highlights issues policymakers and voters should consider before making their decisions.
Deaths from overdoses in America are reaching levels similar to those at the peak of the HIV epidemic. RAND's Bradley D. Stein discusses what actions might help stem the growing problem of heroin and prescription drug addiction.
In this January 2015 Congressional Briefing, RAND researchers Beau Kilmer and Jonathan Caulkins present an overview of their new report, Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions.
On TVW's The Impact news show, Beau Kilmer, RAND Drug Policy Research Center co-director, speaks about being a part of the team selected by the state of Washington to provide research and analysis to regulators on the issues surrounding marijuana legalization. The interview with Kilmer starts at 3:30 and runs until 10:30.
Researchers from the RAND Drug Policy Research Center (DPRC) discuss marijuana legalization, how it differs from decriminalization, its possible consequences, and federal response to state initiatives.
In this June 2012 Congressional Briefing, Lois Davis discusses the health care needs of prisoners who reenter the general population; the roles that health care providers, other social services, and family members play in successful reentry; and recommendations for improving access to care for this population in the current fiscal environment.
A voter initiative to legalize marijuana has qualified for the November 2010 ballot in California. In this July 12, 2010, Congressional Briefing, the codirector of the RAND Drug Policy Research Center discusses the projected revenues, costs, and effects on price and use that may come from legalizing, regulating, and taxing marijuana in California.
In this conference call, the codirector of the RAND Drug Policy Research Center discusses a RAND report that projects the revenues, costs, and effects on price and use that may come from legalizing, regulating, and taxing marijuana in California.